**Work Experience:** 2022/4 - Present, Sun Yat-sen University, First Affiliated Hospital, Secretary of the Party Branch for Faculty and Staff of Hepatobiliary and Pancreatic Surgery, Deputy Director of the Hepatobiliary and Pancreatic Surgery Center, Deputy Director of Liver Surgery 2021/3 - 2022/4, Jieyang People's Hospital, Vice President (Seconded) Sun Yat-sen University, First Affiliated Hospital, Deputy Director of Medical Affairs, Deputy Director of Liver Surgery 2016/12 - Present, Sun Yat-sen University, First Affiliated Hospital, Liver Surgery, Chief Physician 2010/12 - 2016/12, Sun Yat-sen University, First Affiliated Hospital, Liver Surgery, Associate Chief Physician 2012/4 - 2014/1, Medical University of South Carolina, Department of Microbiology & Immunology, Postdoctoral Fellow 2007/12 - 2010/12, Sun Yat-sen University, First Affiliated Hospital, Attending Physician, Lecturer 2004/8 - 2007/12, Sun Yat-sen University, First Affiliated Hospital, Chief Resident **Professional Affiliations:** Guangdong Provincial Health Management Society, Digestive Endoscopy MDT Professional Committee, Chairman Guangdong Provincial Geriatric Health Association, Liver Cancer MDT Professional Committee, Chairman Guangdong Provincial Medical Doctor Association, Hepatobiliary and Pancreatic Surgery Branch, Vice Chairman Guangdong Provincial Medical Association, Hepatobiliary and Pancreatic Surgery Branch, Standing Committee Member Chinese Society of Surgical Endoscopists Alliance, Senior Member International Hepato-Pancreato-Biliary Association China Chapter, Hepatobiliary and Pancreatic MDT Professional Committee, Member Chinese Medical Doctor Association, Liver Cancer Professional Committee, Youth Committee, Member Second Session of Chinese Digestive Surgery Elite Society, Member Chinese Medical Doctor Association, Journal of Surgery Electronic Edition, Editorial Board Member Frontiers in Molecular Biosciences (IF: 6.113), Associate Editor JoVE Video Journal (IF: 1.424), Guest Editor **Research Activities:** The scientific questions addressed in research revolve around urgent clinical needs, such as in-depth investigation into the development and progression of cirrhosis-related hepatocellular carcinoma (HCC), mechanisms of HCC metastasis and recurrence, HCC microenvironment and immunotherapy, identification of precise prognostic indicators for HCC, and development of effective targeted therapies for HCC. Authored/co-authored 18 SCI papers as first/corresponding author, with a total impact factor of 102.886. Journals include Clin Cancer Res (IF: 13.801), J Exp Clin Cancer Res (IF: 12.658), Front Immunol (IF: 8.786), Hepatol Int (IF: 9.029), Front Pharmacol (IF: 5.988), Front Mol Biosci (IF: 6.113), Sci Rep (IF: 4.996), HPB (IF: 3.842), BMC Cancer (IF: 4.638), Ann Transl Med (IF: 3.616), Chemotherapy (IF: 3.549), HEPATOB PANCREAT DIS (IF: 3.355), Hum Pathol (IF: 3.466), Biomed Res Int (IF: 3.246), etc. Additionally, published over 50 articles in domestic core journals. Served as the primary principal investigator for one National Natural Science Foundation project, nine provincial/ministerial-level projects, and one Sun Yat-sen University Young Teacher Cultivation Project under the Basic Scientific Research Operating Expenses of Higher Education Institutions.